trihexyphenidyl has been researched along with Nervous System Disorders in 7 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effectiveness and safety of trihexyphenidyl, scopolamine and botulinum toxin infiltration in the treatment of drooling in children with neurological disorders." | 5.20 | [Drooling therapy in children with neurological disorders]. ( Alonso-Curcó, X; Badosa-Pagès, J; Muchart, J; Paredes-Mercado, C; Póo, P; Táboas-Pereira, MA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Táboas-Pereira, MA | 1 |
| Paredes-Mercado, C | 1 |
| Alonso-Curcó, X | 1 |
| Badosa-Pagès, J | 1 |
| Muchart, J | 1 |
| Póo, P | 1 |
| Krejcová, G | 1 |
| Kassa, J | 1 |
| KAFER, JP | 1 |
| POCH, GF | 1 |
| Greer, M | 1 |
| von Bredow, J | 1 |
| Corcoran, K | 1 |
| Maitland, G | 1 |
| Kaminskis, A | 1 |
| Adams, N | 1 |
| Wade, J | 1 |
| Wilcox, CS | 1 |
| Aminoff, MJ | 1 |
| Kurtz, AB | 1 |
| Slater, JD | 1 |
| Millichap, JG | 1 |
| Pitchford, GL | 1 |
| Millichap, MG | 1 |
1 trial available for trihexyphenidyl and Nervous System Disorders
| Article | Year |
|---|---|
[Drooling therapy in children with neurological disorders].
Topics: Acetylcholine Release Inhibitors; Adolescent; Botulinum Toxins, Type A; Child; Child, Preschool; Fem | 2015 |
6 other studies available for trihexyphenidyl and Nervous System Disorders
| Article | Year |
|---|---|
Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats.
Topics: Animals; Antidotes; Atropine; Behavior, Animal; Benactyzine; Cholinesterase Inhibitors; Cholinestera | 2003 |
[Cycrimine, a new drug in the treatment of Parkinson's disease & Parkinsonism].
Topics: Humans; Nervous System Diseases; Parkinson Disease; Piperidines; Trihexyphenidyl | 1957 |
How to achieve maximum benefit for the patient with Parkinson's disease.
Topics: Aged; Amantadine; Carbidopa; Diagnosis, Differential; Histamine H1 Antagonists; Humans; Levodopa; Ne | 1976 |
Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
Topics: Animals; Cholinesterases; Erythrocytes; Female; Lethal Dose 50; Macaca fascicularis; Male; Nervous S | 1991 |
Comparison of the renin response to dopamine and noradrenaline in normal subjects and patients with autonomic insufficiency.
Topics: Adult; Aged; Autonomic Nervous System; Blood Pressure; Diet; Dopamine; Fecal Incontinence; Humans; H | 1974 |
Anticonvulsant activity of antiparkinsonism agents.
Topics: Animals; Anticonvulsants; Child; Child, Preschool; Electroshock; Female; Glaucoma; Humans; Infant; M | 1968 |